Log in to search using one of your social media accounts:

 

Varian inks Brazilian training, education deal
Varian Medical (NYSE:VAR) said today it inked a software technology training and education cooperation agreement with the Brazil Ministry of Health and seven universities and science and tech institutes in the country. The Palo Alto, Calif.-based medical device maker said the agreement is part of its strategy of partnering with the Ministry of Health to increase quality and access to radiotherapy treatments in Brazil and across Latin America. Varian said that the list of participating institutions includes the Universidade Federal de São Paulo, Universidade Federal de Pernambuco, Instituto Nacional de Telecomun...
Source: Mass Device - May 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Varian Medical Systems Source Type: news

KEYNOTE-189: Chemo + Immunotherapy Now Viable for PD-L1 Low NSCLC KEYNOTE-189: Chemo + Immunotherapy Now Viable for PD-L1 Low NSCLC
While KEYNOTE-189 answered many questions about immuno-oncology for NSCLC, Drs West and Borghaei look forward to results of KEYNOTE-042 for even more answers.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Couple fighting to save life of their baby battling rare brain tumor
Holden Mullen, 14 months, from Naperville, Illinois, is fighting for his life after he was diagnosed with a rare form of brain cancer that affects only about 30 children in the US annually. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2018 Category: Consumer Health News Source Type: news

OncoBreak: Stupid Cancer App; Popular Drugs; Bacteria and Cancer
(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 17, 2018 Category: American Health Source Type: news

Medical News Today: Why is lung cancer so difficult to treat?
Immunotherapies often fail to halt lung cancer's progression. A new study attempts to understand why this is and design a new way to attack it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Obese people are more likely to smoke due to 'addictive' genes
Researchers from the International Agency for Research on Cancer, Lyon, found that for every 4.6kg/m2 increase in BMI, the risk of being a smoker rises by up to 19 per cent, which may be due to DNA. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2018 Category: Consumer Health News Source Type: news

ONCOS-102 Mesothelioma Trial Moves Forward
Oncologists in Spain are recruiting patients for the randomized phase of the pleural mesothelioma clinical trial involving ONCOS-102, the promising immunotherapy vaccine. Optimism surrounding the trial stems from encouraging results obtained recently in the six-patient safety cohort used as a precautionary lead-in. The trial involves the vaccine in combination with standard-of-care chemotherapy for patients with inoperable disease. ONCOS-102 is a scientifically engineered adenovirus that is designed to activate a patient’s immune system to selectively target cancer cells. It is being developed by Targovax, a Scandina...
Source: Asbestos and Mesothelioma News - May 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Viewpoint: China has the upper hand in cancer cell therapy
Cheers went up last August when the U.S. Food and Drug Administration approved the world ’s first CAR-T cancer cell treatment, Novartis’ Kymriah, and again in October when it approved Gilead’s CAR-T treatment for non-Hodgkin's lymphoma. In CAR-T therapy, the immune system’s killer T cells are modified to target specific tumors, giving physicians a powerful new tool to treat canc er. But when it comes to the long-term development of this revolutionary treatment, China is poised to leapfrog… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Source Type: news

Yale Explores Boston addresses the future of cancer treatment
The May 15 event connected Yale alumni and friends with three esteemed faculty members and President Salovey through networking and a panel discussion. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 17, 2018 Category: Universities & Medical Training Source Type: news

Most Efficient, Less Costly Gene Testing Method for NSCLC Most Efficient, Less Costly Gene Testing Method for NSCLC
For genetic testing of patients with non-small cell lung cancer (NSCLC), next-generation sequencing is less costly than other methods, and results are available much sooner.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pearls from: Conor Delaney, MD, PhD
(MedPage Today) -- Implications of growing colon cancer incidence in younger people (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 17, 2018 Category: Gastroenterology Source Type: news

Men May Gain More From Cancer Immunotherapy
Researchers found that all the patients fared better on immunotherapy treatment than they would have on another treatment (or no treatment at all). But following treatment, male cancer patients saw their survival extended by twice as much as female patients. (Source: WebMD Health)
Source: WebMD Health - May 17, 2018 Category: Consumer Health News Source Type: news

Men May Gain More From Cancer Immunotherapy
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 17, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, News, Source Type: news

Medical News Today: Could these 'molecular switches' stop brain cancer?
New research provides further promising evidence that molecular approaches might slow or reverse the progress of glioblastoma, an aggressive brain cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Bipolar Source Type: news

ImaginAb Reconstitutes Scientific Advisory Board
Members include Immuno-Oncology leaders Dr. Antoni Ribas, Dr. Daniel D. Von Hoff and Dr. David Mankoff LOS ANGELES, May 17, 2018 -- (Healthcare Sales & Marketing Network) -- ImaginAb Inc., an immuno-oncology imaging company, today announced the reconst... Biopharmaceuticals, Oncology, Radiology, Personnel ImaginAb , minibodie, PET scan, ImmunoPET (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Breast cancer treatment time could be HALVED
British research from the University of Warwick and the University of Cambridge has revealed the amount of time a person needs on herceptin could be halved from 12 months to six (stock). (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2018 Category: Consumer Health News Source Type: news

New evidence on link between obesity and smoking behaviour from genetic data: obese people at higher risk of smoking
A study by the International Agency for Research on Cancer (IARC) provides new evidence that increased weight and obesity may result in increased smoking. The Cancer Research UK (CRUK)-funded study, involving University of Bristol researchers and published today in the British Medical Journal (BMJ), found that increased body mass index (BMI), body fat percentage, and waist circumference were associated both with a higher risk of being a smoker and with greater smoking intensity, measured by the number of cigarettes smoked per day. These results were consistent in both men and women. (Source: University of Bristol news)
Source: University of Bristol news - May 17, 2018 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

Limiting Chemo to High-Risk Rectal Cancer Called Feasible
(MedPage Today) -- Approach that includes MRI-based selection didn't boost local recurrence rates (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 17, 2018 Category: Gastroenterology Source Type: news

Director Resigns as Irish Cervical Screening Scandal Escalates Director Resigns as Irish Cervical Screening Scandal Escalates
The cervical cancer screening debacle in Ireland, which involves US pathology labs, continues to escalate and has led to the resignation of a Health Service Executive chief.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NCCN expands management team with the hiring of its first chief medical officer
The National Comprehensive Cancer Network is expanding the management team at its Montgomery County headquarters. The NCCN, a nonprofit alliance of more than two dozen cancer centers from around the country, has hired Dr. Wui-Jin Koh for the newly created position of senior vice president and chief medical officer. Koh is radiation oncologist and professor who specializes in the treatment of gynecologic and gastrointestinal malignancies. He currently serves as medical director for radiation oncology… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: John George Source Type: news

NCCN expands management team with the hiring of its first chief medical officer
The National Comprehensive Cancer Network is expanding the management team at its Montgomery County headquarters. The NCCN, a nonprofit alliance of more than two dozen cancer centers from around the country, has hired Dr. Wui-Jin Koh for the newly created position of senior vice president and chief medical officer. Koh is radiation oncologist and professor who specializes in the treatment of gynecologic and gastrointestinal malignancies. He currently serves as medical director for radiation oncology… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 17, 2018 Category: Health Management Authors: John George Source Type: news

Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers
Dr Andrew Kaunitz discusses the impact of hormone therapy on risk for breast cancer in BRCA carriers undergoing risk-reduction surgery.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

' Historic Reversal': No Immediate Tx for Low-Risk Prostate Cancer'Historic Reversal': No Immediate Tx for Low-Risk Prostate Cancer
Use of conservative management for men with low-risk prostate cancer has dramatically increased over the past decade, at least among VA participants.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016
THURSDAY, May 17, 2018 -- In 2016, only 1.9 percent of the 7.6 million eligible smokers were screened for lung cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Immune Checkpoint Inhibitor Efficacy Varies by Sex
THURSDAY, May 17, 2018 -- For patients with advanced cancers, treatment with immune checkpoint inhibitors is associated with improved overall survival, with the magnitude of the benefit sex-dependent, according to research published online May 16 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: What could cause bone pain?
People may feel aches or pains in their bones for a variety of reasons. Many people worry when they experience bone pain because it can be a sign of bone cancer. For this reason, prompt diagnosis is essential. Learn more about bone pain symptoms, the signs of cancer, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

Tanzania:Eye Cancer in Children 'Worrying'
[Citizen] Dar es Salaam -Experts in Tanzania have raised concerns about rising cases of eye cancer also known as Retinoblastoma, which commonly affects children. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2018 Category: African Health Source Type: news

An appeals court says CA can list the herbicide glyphosate as a carcinogen
(Natural News) After much fanfare, a state appeals court has ruled that California can list glyphosate as a carcinogen — and that the state’s ban on discharging the herbicide into public waterways stands, too. Despite Monsanto’s best efforts to keep the toxicity of their product under wraps, the ruling in California is undoubtedly a small... (Source: NaturalNews.com)
Source: NaturalNews.com - May 17, 2018 Category: Consumer Health News Source Type: news

Nigeria:Roche Launches Innovative Medicine Against Breast Cancer in Nigeria
[This Day] Swiss multinational, Roche has launched the subcutaneous formulation of Herceptin, its flagship breast cancer drug in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2018 Category: African Health Source Type: news

Men May Gain More From Cancer Immunotherapy
THURSDAY, May 17, 2018 -- Male cancer patients seem to fare significantly better following immunotherapy treatment than female patients, new research indicates. " Both sex and gender can potentially affect the strength of the body's immune... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 17, 2018 Category: General Medicine Source Type: news

Shorter-Duration Trastuzumab as Effective for HER2+ Early Breast Cancer
Women with HER2-positive early breast cancer achieved similar disease-free survival with 6 months of adjuvant trastuzumab compared with a 12-month duration, according to the phase III PERSEPHONE trial. (Source: CancerNetwork)
Source: CancerNetwork - May 17, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Submissions for the State of Kuwait Prize for the Control of Cancer, Cardiovascular Diseases ...
The State of Kuwait Prize for the Control of Cancer, Cardiovascular Diseases and Diabetes in the Eastern Mediterranean Region is one of several Foundation awards, administered by the World Health Organization, which acknowledges the work of well-known scientists, researchers or dedicated people who have greatly contributed to the advancement of public health.  Purpose The purpose of the prize is to recognize individuals who have made an outstanding contribution in prevention, control or research in one or more of the following disease groups: cancer, cardiovascular disease and diabetes.  Nature of the prize an...
Source: WHO EMRO News - May 17, 2018 Category: Middle East Health Source Type: news

Breast Cancer Patients May Shorten Herceptin Regimen: Study
Title: Breast Cancer Patients May Shorten Herceptin Regimen: StudyCategory: Health NewsCreated: 5/16/2018 12:00:00 AMLast Editorial Review: 5/17/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2018 Category: Cancer & Oncology Source Type: news

Too Few Smokers Get Lifesaving Lung Cancer Tests
Title: Too Few Smokers Get Lifesaving Lung Cancer TestsCategory: Health NewsCreated: 5/16/2018 12:00:00 AMLast Editorial Review: 5/17/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2018 Category: Cancer & Oncology Source Type: news

Men May Gain More From Cancer Immunotherapy
Title: Men May Gain More From Cancer ImmunotherapyCategory: Health NewsCreated: 5/17/2018 12:00:00 AMLast Editorial Review: 5/17/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2018 Category: Cancer & Oncology Source Type: news

Fewer men opt for prostate cancer treatment
A record number of U.S. veterans are taking a wait-and-see approach and bypassing...Read more on AuntMinnie.comRelated Reading: False-positive screening results don't deter patients High-dose radiotherapy lowers prostate cancer recurrence MRI-based risk model improves prostate cancer detection PSMA-PET/CT helps spot early prostate cancer recurrence Lancet: Cancer survival rates improve but vary widely (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2018 Category: Radiology Source Type: news

Immuno-PET tracer offers hope for early cancer treatment
Researchers are developing a PET radiotracer designed to adhere to and illuminate...Read more on AuntMinnie.comRelated Reading: MRI holds promise for immunotherapy but needs more research Novel PET tracer could identify bacterial infections Immuno-PET radiotracers may aid cancer treatment Novel PET tracer aids recurrent prostate cancer patients Radiation, immunotherapy form best team against melanoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2018 Category: Radiology Source Type: news

Bone scan software predicts prostate cancer survival
Researchers using automated software to assess bone scintigraphy scans of patients...Read more on AuntMinnie.comRelated Reading: Hybrid modalities disappoint in bone metastases accuracy ASTRO updates guidelines on painful bone metastases FDG-PET/MRI shows advantages with malignant bone lesions NaF-PET/CT beats scintigraphy, SPECT/CT for bone metastases NaF-PET/CT detects bone mets in prostate cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2018 Category: Radiology Source Type: news

Medical News Today: Cancer: Does sex affect the outcome of immunotherapy?
Therapies that help the immune system to fight tumors have gained popularity over time. But are we leaving a key element — sex — out of clinical trials? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

The Cost of Contralateral Prophylactic Mastectomy The Cost of Contralateral Prophylactic Mastectomy
In this article, the economic value of contralateral prophylactic mastectomy among women with early-stage unilateral breast cancer is explored.Plastic and Reconstructive Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

Geriatric Assessment for Older Patients With Cancer Geriatric Assessment for Older Patients With Cancer
Not only can a geriatric assessment evaluate medical, psychosocial, and functional problems in older patients with cancer, it can also predict toxicity and guide interventions.Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

A New Era of Proactive Melanoma Therapy: Hit Hard, Hit Early A New Era of Proactive Melanoma Therapy: Hit Hard, Hit Early
This editorial discusses the ramifications of three recent, pivotal melanoma trials of targeted and immunotherapies.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Follow-up phase III data showed Roche ’s Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death
Roche today announced follow-up data from the phase III ALEX study, showing that, as an initial treatment, Alecensa ® (alectinib) significantly reduced the risk of disease progression or death (progression-free survival; PFS) by 57% (hazard ratio [HR]= 0.43, 95% CI: 0.32-0.58) compared to crizotinib after two years of follow-up in people with anaplastic lymphoma kinase (ALK)-positive metastatic (advanced) non-sm all cell lung cancer (NSCLC), as assessed by the investigator. (Source: Roche Investor Update)
Source: Roche Investor Update - May 17, 2018 Category: Pharmaceuticals Source Type: news

Follow-up phase III data showed Roche ’s Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death
Roche today announced follow-up data from the phase III ALEX study, showing that, as an initial treatment, Alecensa ® (alectinib) significantly reduced the risk of disease progression or death (progression-free survival; PFS) by 57% (hazard ratio [HR]= 0.43, 95% CI: 0.32-0.58) compared to crizotinib after two years of follow-up in people with anaplastic lymphoma kinase (ALK)-positive metastatic (advanced) non-sm all cell lung cancer (NSCLC), as assessed by the investigator. (Source: Roche Media News)
Source: Roche Media News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel
Roche today announced positive results from the Phase III IMpower150 study of Tecentriq ® (atezolizumab) and Avastin® (bevacizumab) plus carboplatin and paclitaxel (chemotherapy) for the initial (first-line) treatment of chemotherapy-naïve people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - May 17, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel
Roche today announced positive results from the Phase III IMpower150 study of Tecentriq ® (atezolizumab) and Avastin® (bevacizumab) plus carboplatin and paclitaxel (chemotherapy) for the initial (first-line) treatment of chemotherapy-naïve people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Bowel cancer symptoms: Add this popular £1 fruit to your diet to slash risk of disease
BOWEL cancer symptoms are not always easy to spot as they can be mistaken for less serious health conditions. But you can help prevent the disease from developing in the first place by making some simple changes to your diet. Increasing your fibre intake is just of the things you can do. (Source: Daily Express - Health)
Source: Daily Express - Health - May 17, 2018 Category: Consumer Health News Source Type: news

Men ’ s depression may lower chances for pregnancy in couples, NIH study suggests
Women having trouble getting pregnant sometimes try yoga, meditation or mindfulness, and some research suggests that psychological stress may affect infertility. But what about men: Does their mental state affect a couple's ability to conceive? The latest research on this subject was published Thursday in the journal Fertility and Sterility and suggests that a link between mental health […]Related:CDC comes close to an all-clear on romaine lettuce as E. coli outbreak nears historic levelSurrogate mothers ask Supreme Court to stop ‘exploitation’ of women and babiesMore men with low-risk pro...
Source: Washington Post: To Your Health - May 17, 2018 Category: Consumer Health News Source Type: news

Depression in men may lower chances for pregnancy, NIH study suggests
Women having trouble getting pregnant sometimes try yoga, meditation or mindfulness, and some research suggests that psychological stress may affect infertility. But what about men: Does their mental state affect a couple's ability to conceive? The latest research on this subject was published Thursday in the journal Fertility and Sterility and suggests that a link between mental health […]Related:CDC comes close to an all-clear on romaine lettuce as E. coli outbreak nears historic levelSurrogate mothers ask Supreme Court to stop ‘exploitation’ of women and babiesMore men with low-risk pro...
Source: Washington Post: To Your Health - May 17, 2018 Category: Consumer Health News Source Type: news

AgriLife scientists uncover a new face of a famous protein, SWI2/SNF2 ATPase
(Texas A&M AgriLife Communications) A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression that causes life-threatening diseases such as cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 17, 2018 Category: Biology Source Type: news